Arthneeti
Order winNotableFiled on BSE ·

Aster DM Healthcare receives NCLT approval for Scheme of Amalgamation with QCIL

Aster DM Quality Care · Healthcare Services

Arthneeti Research DeskPublished 1 min read

Key highlights

  • NCLT Hyderabad Bench approved amalgamation scheme between Quality Care India Limited and Aster DM Healthcare Limited on 23 June 2026
  • Certified true copy of the order received on 23 June 2026, available on company website
  • Scheme will become effective after filing with Registrar of Companies and other conditions; QCIL to dissolve without winding up upon effectiveness

Why it's rated notable: The filing gives no value for the amalgamation, and it is a merger into the company's own structure, so it is rated medium at most, with the NCLT approval received on 23 June 2026 as the binding fact and the scheme still needing ROC filing and other conditions before it takes effect.

Original filing

Intimation Regarding Receipt Of Certified True Copy Of The Order Passed By The Hon'Ble National Company Law Tribunal, Hyderabad Bench, Approving The Scheme Of Amalgamation

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Aster DM Quality Care

Other order win filings this fortnight

All order win filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.